BPH Global Ltd Total Assets
BPH Global Ltd total assets. Based on the latest financial reports, BPH Global Ltd (BP8) holds total assets worth AU$1.38 Million AUD (≈ $973.66K USD) as of June 2026. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. Also see BPH Global Ltd (BP8) market capitalisation for the company's overall valuation and market capitalisation.
Total Assets of BPH Global Ltd (1999–2026)
Total assets of BPH Global Ltd from 1999 to 2026. This chart illustrates how BPH Global Ltd's total assets have evolved over time, based on quarterly financial data. See today's stock price for BPH Global Ltd for real-time trading data and today's change.
BPH Global Ltd - Asset Composition Analysis
BPH Global Ltd Total Assets Breakdown (June 2026)
BPH Global Ltd total assets breakdown as of June 2026. BPH Global Ltd's total assets of AU$1.38 Million consist of 97.4% current assets and 2.6% non-current assets.
| Asset Category | Amount (AUD) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | AU$0.00 | 18.9% |
| Accounts Receivable | AU$807.16K | 58.7% |
| Inventory | AU$0.00 | 0.0% |
| Property, Plant & Equipment | AU$0.00 | 0.0% |
| Intangible Assets | AU$0.00 | 0.0% |
| Goodwill | AU$0.00 | 0.0% |
Asset Composition Trend (1999–2026)
This chart illustrates how BPH Global Ltd's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. Explore BPH Global Ltd working capital to net assets to assess how much short-term liquidity the company maintains relative to its equity base.
Key Asset Composition Facts
- Current vs. Non-Current Assets: BPH Global Ltd's current assets represent 97.4% of total assets in 2026, an increase from 34.1% in 1999.
- Cash Position: Cash and equivalents constituted 18.9% of total assets in 2026, up from 16.1% in 1999.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 0.0% of total assets, a decrease from 19.0% in 1999.
- Asset Diversification: The largest asset category is accounts receivable at 58.7% of total assets.
BPH Global Ltd Competitors by Total Assets
Key competitors of BPH Global Ltd based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Richter Gedeon Vegyészeti Gyár Nyilvánosan Muködo Rt
F:RIG2
|
Germany | €1.60 Trillion |
|
Changchun High & New Technology Industries Group Inc
SHE:000661
|
China | CN¥30.77 Billion |
|
Chengdu Kanghong Pharmaceuticals Group Co Ltd
SHE:002773
|
China | CN¥9.94 Billion |
|
Zhejiang Hisun Pharmaceutical Co Ltd
SHG:600267
|
China | CN¥13.81 Billion |
|
Shenzhen Chipscreen Biosciences Co
SHG:688321
|
China | CN¥3.63 Billion |
|
Cronos Group Inc
TO:CRON
|
Canada | CA$1.18 Billion |
|
Jiangsu Kanion Pharmaceutical Co Ltd
SHG:600557
|
China | CN¥6.74 Billion |
|
HPGC Renmintongtai Pharmaceutical Corp
SHG:600829
|
China | CN¥7.35 Billion |
BPH Global Ltd - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 0.59 | 0.27 | 2.82 |
| Quick Ratio | 0.59 | 0.20 | 2.58 |
| Cash Ratio | 0.00 | 0.00 | 1.80 |
| Working Capital | AU$-918.67K | AU$-1.47 Million | AU$5.33 Million |
BPH Global Ltd - Advanced Valuation Insights
This section examines the relationship between BPH Global Ltd's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 2.63 |
| Latest Market Cap to Assets Ratio | 1.71 |
| Asset Growth Rate (YoY) | 154.4% |
| Total Assets | AU$1.38 Million |
| Market Capitalization | $2.35 Million USD |
Valuation Analysis
Above Book Valuation: The market values BPH Global Ltd's assets above their book value (1.71x), reflecting positive investor sentiment about the company's future prospects.
Rapid Asset Growth: BPH Global Ltd's assets grew by 154.4% over the past year, indicating significant expansion of the company's resource base.
Annual Total Assets for BPH Global Ltd (1999–2026)
The table below shows the annual total assets of BPH Global Ltd from 1999 to 2026.
| Year | Total Assets | Change |
|---|---|---|
| 2026-06-30 | AU$1.38 Million ≈ $973.66K |
+154.35% |
| 2025-06-30 | AU$541.00K ≈ $382.79K |
-21.80% |
| 2024-06-30 | AU$691.84K ≈ $489.52K |
-67.11% |
| 2023-06-30 | AU$2.10 Million ≈ $1.49 Million |
-72.41% |
| 2022-06-30 | AU$7.62 Million ≈ $5.39 Million |
-17.40% |
| 2021-06-30 | AU$9.23 Million ≈ $6.53 Million |
+811.65% |
| 2020-06-30 | AU$1.01 Million ≈ $716.46K |
-58.36% |
| 2019-06-30 | AU$2.43 Million ≈ $1.72 Million |
+53.73% |
| 2018-06-30 | AU$1.58 Million ≈ $1.12 Million |
-39.93% |
| 2017-06-30 | AU$2.63 Million ≈ $1.86 Million |
-46.06% |
| 2016-06-30 | AU$4.88 Million ≈ $3.45 Million |
+36.32% |
| 2015-06-30 | AU$3.58 Million ≈ $2.53 Million |
+16865.99% |
| 2014-06-30 | AU$21.11K ≈ $14.93K |
-99.99% |
| 2007-06-30 | AU$280.75 Million ≈ $198.65 Million |
+36.34% |
| 2006-06-30 | AU$205.93 Million ≈ $145.71 Million |
+49.21% |
| 2005-06-30 | AU$138.01 Million ≈ $97.65 Million |
+71.47% |
| 2004-06-30 | AU$80.48 Million ≈ $56.95 Million |
+112.85% |
| 2003-06-30 | AU$37.81 Million ≈ $26.75 Million |
+114.37% |
| 2002-06-30 | AU$17.64 Million ≈ $12.48 Million |
-0.12% |
| 2001-06-30 | AU$17.66 Million ≈ $12.50 Million |
+34.75% |
| 2000-06-30 | AU$13.11 Million ≈ $9.27 Million |
+8.86% |
| 1999-06-30 | AU$12.04 Million ≈ $8.52 Million |
-- |
About BPH Global Ltd
BPH Global Ltd, together with its subsidiaries, engages in sourcing, producing, marketing, and selling traditional medicines in Australia, Singapore, China, and Southeast Asia. The company's products include raw bird's nest and processed bird's nest products, and Caulerpa Lentillifera, sea grapes and seaweeds. Its products are used in the food, nutrition, healthcare, health supplements, cosmetics… Read more